Revised consensus standards
This article was originally published in The Gray Sheet
CDRH will provide a transition period "on a case-by-case basis" during which both old and new versions of a standard will be recognized, according to a 11July 22 guidance. Declarations of conformity can still be accepted during the transition period, which will be included in the "supplemental information sheet" accompanying recognition of a standard. The guidance, superseding a June 2001 document, also clarifies that standards will become effective when their recognition is posted for pre-publication, and not merely on the date of the Federal Register notice...
You may also be interested in...
India has removed export restrictions on APIs and formulations imposed by the country in March. However, certain measures have been kept in place to ensure that domestic requirements are met for in-demand products such as hydroxychloroquine and paracetamol.
EU Approvals: Takeda advances its targeted ALK-positive NSCLC tyrosine kinase inhibitor into early lines of therapy, while Bayer and Finland’s Orion gain clearance for their androgen receptor inhibitor for prostate cancer.
The pharma giants are joining forces to help the UK reach its ambitious target of testing 100,000 people a day for coronavirus by the end of April.